Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators
An introduction to the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), the largest study of cardiovascular disease in HIV
View Publication